ArticleFrontiers in oncology2023

Targeted therapy for intractable cancer on the basis of molecular profiles: An open-label, phase II basket trial (Long March Pathway).

Xiao-Dong Jiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.